Trial intelligence / Profile preview

Levetiracetam in postherpetic neuralgia

NCT00160511Phase 2Completed

Sponsor
UCB
Start
Apr 2004
Primary completion
Aug 2005
Modality
Small Molecules
01

Overview

Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing Levetiracetam Arm with Placebo Arm (2 arms). Primary endpoint: Absolute change in the average weekly Pain Intensity Scale. Started Apr 2004; status: completed.

02

Drugs

levetiracetam
03

Conditions

postherpetic neuralgia (PHN)

Beyond the preview

Go deeper on NCT00160511.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00160511.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call